Developmental changes in cellular and extracellular structural macromolecules in the secondary palate and in the nasal cavity of the mouse

European Journal of Oral Sciences

Volumn 118, Issue 3, 2010, Pages 221-236

  Sani, Forugh Vaziri ^a   Kaartinen, Vesa ^b   El Shahawy, Maha ^a   Linde, Anders ^a   Gritli Linde, Amel ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Cleaved lamin A; Gonadotropin releasing hormone neurons; Keratin 17; Keratin 8; Olfactory nerve

Indexed keywords

CD15 ANTIGEN; CHONDROITIN SULFATE; CSPG2 PROTEIN, MOUSE; CYTOKERATIN 14; CYTOKERATIN 15; CYTOKERATIN 6; CYTOKERATIN 8; CYTOSKELETON PROTEIN; FOXA1 PROTEIN, MOUSE; HEPARAN SULFATE; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; KERATIN; KRT1 14 PROTEIN, MOUSE; KRT1 15 PROTEIN, MOUSE; KRT1 17 PROTEIN, MOUSE; KRT1-14 PROTEIN, MOUSE; KRT1-15 PROTEIN, MOUSE; KRT1-17 PROTEIN, MOUSE; KRT8 PROTEIN, MOUSE; LAMIN A; MYOSIN HEAVY CHAIN; MYOSIN IIA; PROTEIN SERINE THREONINE KINASE; SCLEROPROTEIN; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; TGFB3 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA3; VERSICAN; MACROMOLECULE;

ANIMAL; APOPTOSIS; ARTICLE; CELL ADHESION; CYTOLOGY; EPITHELIUM; GESTATIONAL AGE; INNERVATION; MACROMOLECULE; MOUSE; NOSE CAVITY; PALATE; PHYSIOLOGY; PRENATAL DEVELOPMENT; SIGNAL TRANSDUCTION; UPREGULATION; VOMER; EMBRYOLOGY;

ANIMALS; ANTIGENS, CD15; APOPTOSIS; CELL ADHESION; CHONDROITIN SULFATES; CYTOSKELETAL PROTEINS; EPITHELIUM; EXTRACELLULAR MATRIX PROTEINS; GESTATIONAL AGE; HEPARITIN SULFATE; HEPATOCYTE NUCLEAR FACTOR 3-ALPHA; KERATIN-14; KERATIN-15; KERATIN-6; KERATIN-8; KERATINS; LAMIN TYPE A; MACROMOLECULAR SUBSTANCES; MICE; MYOSIN HEAVY CHAINS; NASAL CAVITY; NONMUSCLE MYOSIN TYPE IIA; PALATE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA3; UP-REGULATION; VERSICANS; VOMER;

EID: 77954009512     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2010.00732.x     Document Type: Article

References (68)

1. Chai Y, Maxson RE. Recent advances in craniofacial morphogenesis. Dev Dyn 2006, 235:2353-2375.
2. Gritli-Linde A. Molecular control of secondary palate development. Dev Biol 2007, 301:309-326.
3. Gritli-Linde A. The etiopathogenesis of cleft lip and cleft palate: usefulness and caveats of mouse models. Curr Top Dev Biol 2008, 84:37-138.
4. Vieira AR. Unraveling human cleft lip and palate research. J Dent Res 2008, 87:119-125.
5. Jiang R, Bush JO, Lidral A. Development of the upper lip: morphogenetic and molecular mechanisms. Dev Dyn 2006, 235:1152-1166.
6. Carette MJM, Lane BE, Ferguson MWJ. Differentiation of mouse embryonic palatal epithelium in culture: selective cytokeratin expression distinguishes between oral, medial edge and nasal epithelial cells. Differentiation 1991, 47:149-161.
7. Montenegro MA, Rojas M, Dominguez S, Vergara A. Cytokeratin, vimentin and E-cadherin immunodetection in the embryonic palate in two strains of mice with different susceptibility to glucocorticoid-induced clefting. J Craniofac Genet Dev Biol 2000, 20:137-143.
8. Dudas M, Li WY, Kim J, Yang A, Kaartinen V. Palatal fusion - Where do the midline cells go? A review on cleft palate, a major human birth defect. Acta Histochem 2007, 109:1-14.
9. Pratt RM, Coggins JF, Wilk AL, King CTG. Acid mucopolysaccharide synthesis in the secondary palate of the developing rat at the time of rotation and fusion. Dev Biol 1973, 32:230-237.
10. Ferguson MWJ. Palatal shelf elevation in the Wistar rat fetus. J Anat 1978, 125:555-577.
11. Knudsen TB, Bulleit RF, Zimmerman EF. Histochemical localization of glycosaminoglycans during morphogenesis of the secondary palate in mice. Anat Embryol 1985, 173:137-142.
12. Singh GD, Moxham BJ, Langley MS, Waddington RJ, Embery G. Changes in the composition of glycosaminoglycan biosynthesis during normal palatogenesis in the rat. Arch Oral Biol 1994, 39:401-407.
13. Dudas M, Kaartinen V. Tgf-beta superfamily and mouse craniofacial development: interplay of morphogenetic proteins and receptor signaling controls normal formation of the face. Curr Top Dev Biol 2005, 66:65-133.
14. Gritli-Linde A, Lewis P, McMahon AP, Linde A. The whereabouts of a morphogen: direct evidence for short- and graded long-range activity of Hedgehog signaling peptides. Dev Biol 2001, 236:364-386.
15. Angerer LM, Angerer RC. In situ hybridization to cellular RNA with radiolabelled RNA probes. In situ Hybridization. A Practical Approach 1992, 15-32. Wilkinson DG, ed, Oxford, Oxford University Press
16. Fuchs E, Weber K. Intermediate filaments: structure, dynamics, function and disease. Annu Rev Biochem 1994, 63:345-382.
17. Coulombe PA, Omary MB. " Hard" and " soft" principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 2002, 14:110-122.
18. Kirfel J, Magin TM, Reichelt J. Keratins: a structural scaffold with emerging functions. Cell Mol Life Sci 2003, 60:56-71.
19. Moll R, Francke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 3:11-24.
20. Porter RM, Lane EB. Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet 2003, 19:278-285.
21. McGowan KM, Coulombe PA. Onset of keratin 17 expression coincides with the definition of major epithelial lineages during skin development. J Cell Biol 1998, 143:469-486.
22. Mazzalupo S, Coulombe PA. A reporter based on a human keratin 6 gene promoter is specifically expressed in the periderm of mouse embryo. Mech Dev 2001, 100:65-69.
23. Mazzalupo S, Wong P, Martin P, Coulombe PA. Role for keratin 6 and 17 during wound closure in embryonic mouse skin. Dev Dyn 2003, 226:356-365.
24. Tobet SA, Schwarting GA. Recent progress in gonadotropin-releasing hormone neuronal migration. Endocrinology 2006, 147:1159-1165.
25. Vaziri Sani F, Hallberg K, Harfe BD, McMahon AP, Linde A, Gritli-Linde A. Fate-mapping of the epithelial seam during palatal fusion rules out epithelial-mesenchymal transformation. Dev Biol 2005, 285:490-495.
26. Murray SA, Oram KF, Gridley T. Multiple functions of Snail family genes during palate development in mice. Development 2007, 134:1789-1797.
27. Besnard V, Wert SE, Hull WM, Whitsett JA. Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues. Gene Expr Patterns 2004, 5:193-208.
28. Fitchett JE, Hay ED. Medial edge epithelium transforms to mesenchyme after embryonic palatal shelves fuse. Dev Biol 1989, 131:455-474.
29. Cuervo R, Covarrubias L. Death is the major fate of medial edge epithelial cells and the cause of basal lamina degradation during palatogenesis. Development 2004, 131:15-24.
30. Solter D, Knowles BB. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 1978, 75:5565-5569.
31. Fox N, Damjanov I, Martinez-Hernandez A, Knowles BB, Solter D. Immunohistochemical localization of the early embryonic antigen in post-implantation mouse embryo and fetal and adult tissues. Dev Biol 1981, 83:391-398.
32. Bird JM, Kimber SJ. Oligosaccharides containing fucose linked alpha (1-3) and alpha (1-4) to N-acetylglucosamine cause decompaction of mouse morulae. Dev Biol 1984, 104:449-460.
33. Marani E, van Oers JW, Tetteroo PA, Poelmann RE, van der Veeken J, Deenen MG. Stage specific embryonic carbohydrate surface antigens of primordial germ cells in mouse embryos: FAL (SSEA-1) and globoside (SSEA-3). Acta Morphol Neerl Scand 1986, 24:103-110.
34. Capela A, Temple S. LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal. Neuron 2002, 35:867-875.
35. Capela A, Temple S. LeX is expressed by principal progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1. Dev Biol 2006, 291:300-313.
36. Gocht A, Struckhoff G, Löhler J. CD15-containing glycoconjugates in the central nervous system. Histol Histopathol 1996, 11:1007-1028.
37. Dvorak P, Hampl A, Jirmanova L, Pacholikova J, Kusakabe M. Embryoglycan ectodomain regulate biological activity of FGF-2 to embryonic stem cells. J Cell Sci 1998, 111:2945-2952.
38. Plank J, Mai JK. Developmental expression of the 3-fucosyl-N-acetyl-lactosamine/CD15 epitope by an olfactory receptor population and in the olfactory bulb of the rat. Dev Brain Res 1992, 66:257-261.
39. Hakomori SI. LeX and related structures as adhesion molecules. Histochem J 1992, 24:771-776.
40. Mai J, Marani E, Hakomori SI. Guest editorial. Histochem J 1992, 24:759-760.
41. Gruenbaum Y, Margalit A, Goldman RD, Shumaker DK, Wilson KL. The nuclear lamina comes of age. Nat Rev Mol Cell Biol 2005, 6:21-31.
42. Bridger JM, Foeger N, Kill IR, Herrmann H. The nuclear lamina. Both a structural framework and a platform for genome organization. FEBS J 2007, 274:1354-1361.
43. Oberhammer FA, Hochegger K, Fröschl G, Tiefenbacher R. Chromatin condensation during apoptosis is accompanied by degradation of lamin A+B, without enhanced activation of cdc2 kinase. J Cell Biol 1994, 126:827-837.
44. Rao L, Perez D, White E. Lamin proteolysis facilitates nuclear events during apoptosis. J Cell Biol 1996, 135:1441-1455.
45. Orth K, Chinnaiyan AM, Garg M, Froelich CJ, Dixit VM. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J Biol Chem 1996, 271:16443-16446.
46. Slee EA, Adrain C, Martin SJ. Executioner caspase-3, -6 and -7 perform distinct, non-redundant, roles during the demolition phase of apoptosis. J Biol Chem 2000, 276:7320-7326.
47. Broers JLV, Bronnenberg NMHJ, Kuijpers HJH, Schutte B, Hutchison CJ, Ramaekers FCS. Partial clavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis. Eur J Cell Biol 2002, 81:677-691.
48. Shuler CF, Guo Y, Majumder A, Luo RY. Molecular and morphologic changes during the epithelial-mesenchymal transformation of palatal shelf medial edge epithelium in vivo. Int J Dev Biol 1991, 35:463-472.
49. Shuler CF, Halpern DE, Guo Y, Sank AC. Medial edge epithelium fate traced by cell lineage analysis during epithelial-mesenchymal transformation in vivo. Dev Biol 1992, 154:318-330.
50. Griffith CM, Hay ED. Epithelial-mesenchymal transformation during palatal fusion: carboxyfluorescein traces cells at light and electron microscopy levels. Development 1992, 116:1087-1099.
51. Nawshad A, Hay ED. TGF-beta3 signaling activates transcription of the LEF1 gene to induce epithelial-mesenchymal transformation (EMT) during mouse palate development. J Cell Biol 2003, 163:1291-1301.
52. Nawshad A, La Gamba ED, Hay ED. Transforming growth factor β (TGFβ) signaling in palatal growth, apoptosis and epithelial mesenchymal transformation (EMT). Arch Oral Biol 2004, 49:675-689.
53. Jin JZ, Ding J. Analysis of cell migration, transdifferentiation and apoptosis during mouse secondary palate fusion. Development 2006, 133:3341-3347.
54. Nawshad A. Palatal seam disintegration: to die or not to die? that is no longer the question. Dev Dyn 2008, 237:2643-2656.
55. Rice DPC. Craniofacial anomalies: from development to molecular pathogenesis. Curr Mol Med 2005, 5:699-722.
56. Dudas M, Kim J, Li WY, Nagy A, Larsson J, Karlsson S, Chai Y, Kaartinen V. Epithelial and ectomesenchymal role of the type I TGF-β receptor ALK5 during facial morphogenesis and palatal fusion. Dev Biol 2006, 296:298-314.
57. Xu X, Han J, Yoshihiro I, Bringas P, Urata MM, Chai Y. Cell autonomous requirement for Tgfbr2 in the disappearence of medial edge epithelium during palatal fusion. Dev Biol 2006, 297:238-248.
58. Gritli-Linde A, Hallberg K, Harfe BD, Reyahi A, Kannius-Janson M, Nilsson J, Cobourne MT, Sharpe PT, McMahon AP, Linde A. Abnormal hair development and apparent follicular transformation to mammary gland in the absence of Hedgehog signaling. Dev Cell 2007, 12:99-112.
59. Aszódi A, Legate KL, Nakchbandi I, Fässler R. What mouse mutants teach us about extracellular matrix function. Annu Rev Cell Dev Biol 2006, 22:591-621.
60. Lazzaro C. Sul meccanismo di chiusura del palato secondario. Monit Zool Ital 1940, 51:249-273.
61. Larsson KS. Studies on the closure of secondary palate, IV. Autoradiographic and histochemical studies of mouse embryos from cortisone-treated mothers. Acta Morphol Neerl Scand 1962, 4:369-386.
62. Gato A, Martinez ML, Tudela C, Alonso I, Moro JA, Formoso MA, Ferguson MWJ, Martínez-Álvarez C. TGF-β3-induced chondroitin sulphate proteoglycan mediates palatal shelf adhesion. Dev Biol 2002, 250:393-405.
63. Srivastava HC, Rao PP. Movement of palatal shelves during secondary palate closure in rat. Teratology 1979, 19:87-104.
64. Wight TN. Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 2002, 14:617-623.
65. Zhang Y, Mori T, Iseki K, Hagino S, Takaki H, Takeuchi M, Hikake T, Tase C, Murakawa M, Yokoya S, Wanaka A. Differential expression of Decorin and Biglycan genes during palatogenesis in normal and retinoic acid-treated mice. Dev Dyn 2003, 226:618-626.
66. Heath KE, Campos-Barros A, Toren A, Rozenfeld-Granot G, Carlsson LE, Savige J, Denison JC, Gregory MC, White JG, Barker DF, Greinacher A, Epstein CJ, Glucksman MJ, Martignetti JA. Nonmuscle myosin heavy chain IIa mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. Am J Hum Genet 2001, 69:1033-1045.
67. Marigo V, Nigro A, Pecci A, Montanaro D, Di Stazio M, Balduini C, Savoia A. Correlation between the clinical phenotypes of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains. Genomics 2004, 83:1125-1133.
68. Martinelli M, Di Stazio M, Scapoli L, Marchesini J, Di Bari F, Pezzetti F, Carinci F, Palmieri A, Carinci P, Savoia A. Cleft lip with or without cleft palate: implication of the heavy chain of non-muscle myosin IIA. J Med Genet 2007, 44:387-392.